Association between paraoxonases gene expression and oxidative stress in hepatotoxicity induced by CCl4

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Hafez, Mohamed M ^a   Al Shabanah, Othman A ^a   Al Harbi, Naif O ^a   Al Harbi, Mohamed M ^a   Al Rejaie, Salim S ^a   Alsurayea, Saad M ^b   Sayed Ahmed, Mohamed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Riyadh Regional Laboratory and Blood Bank   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLS; AMINO ACIDS; CYTOLOGY; HYDROGEN; HYDROGEN PEROXIDE; OLIVE OIL; OXIDATION; OXIDATIVE STRESS; PEPTIDES; PEROXIDES; PLANTS (BOTANY); POLYMERASE CHAIN REACTION; SOLVENTS;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATP-BINDING CASSETTE TRANSPORTER 1; GLUTATHIONE S-TRANSFERASES; HEPATOPROTECTIVE EFFECTS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; WESTERN BLOT TECHNIQUES;

GENE EXPRESSION;

ABC TRANSPORTER A1; ALANINE AMINOTRANSFERASE; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 3; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CATALASE; CHOLESTEROL; DIMETHYL SULFOXIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HIGH DENSITY LIPOPROTEIN; HYDROGEN PEROXIDE; LIPID; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIVE OIL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; RUTOSIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ISOENZYME;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA DAMAGE; ENZYME BLOOD LEVEL; EXPERIMENTAL LIVER INJURY; GENE EXPRESSION; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; WESTERN BLOTTING; WISTAR ALBINO GLAXO RAT; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GENETICS; INTOXICATION; LIPID METABOLISM; LIVER; METABOLISM; RANDOMIZATION; TOXIC HEPATITIS; WISTAR RAT;

ANIMALS; ARYLDIALKYLPHOSPHATASE; CARBON TETRACHLORIDE; CARBON TETRACHLORIDE POISONING; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION; ISOENZYMES; LIPID METABOLISM; LIVER; MALE; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RUTIN;

EID: 84914694814     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/893212     Document Type: Article

References (65)

1. Thilakchand K. R., Mathai R. T., Simon P., Hepatoprotective properties of the Indian gooseberry (Emblica officinalis Gaertn): a review. Food & Function 2013 4 10 1431 1441
2. Kamisan F. H., Yahya F., Mamat S. S., Effect of methanol extract of dicranopteris linearis against carbon tetrachloride- induced acute liver injury in rats. BMC Complementary and Alternative Medicine 2014 14 1, article 123 10.1186/1472-6882-14-123
3. Hsu D.-Z., Li Y.-H., Chu P.-Y., Chien S.-P., Chuang Y.-C., Liu M.-Y., Attenuation of endotoxin-induced oxidative stress and multiple organ injury by 3,4-methylenedioxyphenol in rats. Shock 2006 25 3 300 305 10.1097/01.shk.0000194719.82845.39 2-s2.0-33646118001
4. Kohen R., Nyska A., Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic Pathology 2002 30 6 620 650 10.1080/01926230290166724 2-s2.0-0036867895
5. Adesanoye O. A., Farombi E. O., Hepatoprotective effects of Vernonia amygdalina (astereaceae) in rats treated with carbon tetrachloride. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft fur Toxikologische Pathologie 2010 62 2 197 206
6. Blomhoff R., Dietary antioxidants and cardiovascular disease. Current Opinion in Lipidology 2005 16 1 47 54 10.1097/00041433-200502000-00009 2-s2.0-14744283955
7. Pinnell S. R., Cutaneous photodamage, oxidative stress, and topical antioxidant protection. Journal of the American Academy of Dermatology 2003 48 1 1 22 10.1067/mjd.2003.16
8. Abazov V. M., Abbott B., Abolins M., Search for neutral supersymmetric Higgs Bosons in multijet events at sqrt[s]=1.96 TeV. Physical Review Letters 2005 95 15 151801
9. Costa L. G., Vitalone A., Cole T. B., Modulation of paraoxonase (PON1) activity. Biochemical pharmacology 2005 69 4 541 550
10. Reddy S. T., Wadleigh D. J., Grijalva V., Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 4 542 547
11. Draganov D. I., Human PON3, effects beyond the HDL: clues from human PON3 transgenic mice. Circulation Research 2007 100 8 1104 1105
12. Ng C. J., Shih D. M., Hama S. Y., Villa N., Navab M., Reddy S. T., The paraoxonase gene family and atherosclerosis. Free Radical Biology and Medicine 2005 38 2 153 163 10.1016/j.freeradbiomed.2004.09.035 2-s2.0-10644244414
13. Seo D., Goldschmidt-Clermont P., The paraoxonase gene family and atherosclerosis. Current Atherosclerosis Reports 2009 11 3 182 187 10.1007/s11883-009-0029-3 2-s2.0-65449133540
14. Reddy S. T., Devarajan A., Bourquard N., Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? Current Opinion in Lipidology 2008 19 4 405 408
15. Ng C. J., Wadleigh D. J., Gangopadhyay A., Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. The Journal of Biological Chemistry 2001 276 48 44444 44449
16. Simpson K. J., Henderson N. C., Bone-Larson C. L., Lukacs N. W., Hogaboam C. M., Kunkel S. L., Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles. Clinical Science 2003 104 1 47 63 10.1042/CS20020137 2-s2.0-0037284514
17. Marsillach J., Bertran N., Camps J., The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease. Clinical Biochemistry 2005 38 12 1138 1140
18. Czaja M. J., Geerts A., Xu J., Schmiedeberg P., Ju Y., Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. Journal of Leukocyte Biology 1994 55 1 120 126
19. 4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complementary and Alternative Medicine 2012 12, article 178 10.1186/1472-6882-12-178
20. Hefnawy H. T. M., Ramadan M. F., Protective effects of Lactuca sativa ethanolic extract on carbon tetrachloride induced oxidative damage in rats. Asian Pacific Journal of Tropical Disease 2013 3 4 277 285
21. Ogeturk M., Kus I., Colakoglu N., Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. Journal of Ethnopharmacology 2005 97 2 273 280
22. Potter J. D., Cancer prevention: epidemiology and experiment. Cancer Letters 1997 114 1-2 7 9
23. Huntley A. L., The health benefits of berry flavonoids for menopausal women: cardiovascular disease, cancer and cognition. Maturitas 2009 63 4 297 301
24. Alonso-Castro A. J., Dominguez F., Garcia-Carranca A., Rutin exerts antitumor effects on nude mice bearing SW480 tumor. Archives of Medical Research 2013 44 5 346 351
25. Sikder K., Kesh S. B., Das N., The high antioxidative power of quercetin (aglycone flavonoid) and its glycone (rutin) avert high cholesterol diet induced hepatotoxicity and inflammation in Swiss albino mice. Food & Function 2014 5 6 1294 1303
26. Bear W. L., Teel R. W., Effects of citrus flavonoids on the mutagenicity of heterocyclic amines and on cytochrome P450 1A2 activity. Anticancer Research 2000 20 5B 3609 3614
27. Chen S.-S., Gong J., Liu F.-T., Mohammed U., Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 2000 100 4 471 480 10.1046/j.1365-2567.2000.00045.x
28. Tacke F., Luedde T., Trautwein C., Inflammatory pathways in liver homeostasis and liver injury. Clinical Reviews in Allergy & Immunology 2009 36 1 4 12
29. Tseng C. K., Lin C. K., Chang H. W., Aqueous extract of Gracilaria tenuistipitata suppresses LPS-induced NF-kappaB and MAPK activation in RAW 264.7 and rat peritoneal macrophages and exerts hepatoprotective effects on carbon tetrachloride-treated rat. PloS ONE 2014 9 1 e86557
30. Kim H. Y., Park J., Lee K. H., Ferulic acid protects against carbon tetrachloride-induced liver injury in mice. Toxicology 2011 282 3 104 111 10.1016/j.tox.2011.01.017
31. Aruoma O. I., Methodological considerations for characterizing potential antioxidant actions of bioactive components in plant foods. Mutation Research 2003 523-524 9 20
32. Hu Y. Y., Liu C. H., Wang R. P., Protective actions of salvianolic acid A on hepatocyte injured by peroxidation in vitro. World Journal of Gastroenterology (WJG) 2000 6 3 402 404
33. Tsimikas S., Miller Y. I., Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications. Current Pharmaceutical Design 2011 17 1 27 37
34. Zhou J. R., Erdman J. W. Jr., Phytic acid in health and disease. Critical Reviews in Food Science and Nutrition 1995 35 6 495 508 10.1080/10408399509527712
35. Sreelatha S., Padma P. R., Umadevi M., Protective effects of Coriandrum sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats. Food and Chemical Toxicology 2009 47 4 702 708
36. Yadav P., Sarkar S., Bhatnagar D., Action of capparis decidua against alloxan-induced oxidative stress and diabetes in rat tissues. Pharmacological Research: The Official Journal of the Italian Pharmacological Society 1997 36 3 221 228
37. Khan M. R., Rizvi W., Khan G. N., Carbon tetrachloride-induced nephrotoxicity in rats: protective role of digera muricata. Journal of Ethnopharmacology 2009 122 1 91 99
38. Blokhina O., Virolainen E., Fagerstedt K. V., Antioxidants, oxidative damage and oxygen deprivation stress: a review. Annals of Botany 2003 91 179 194 10.1093/aob/mcf118 2-s2.0-0037237973
39. Scott M. D., Lubin B. H., Zuo L., Erythrocyte defense against hydrogen peroxide: preeminent importance of catalase. The Journal of Laboratory and Clinical Medicine 1991 118 1 7 16
40. Aviram M., Rosenblat M., Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radical Biology & Medicine 2004 37 9 1304 1316
41. Camps J., Marsillach J., Joven J., Measurement of serum paraoxonase-1 activity in the evaluation of liver function. World Journal of Gastroenterology 2009 15 16 1929 1933
42. Zhang C., Peng W., Jiang X., Transgene expression of human PON1 Q in mice protected the liver against CCl4-induced injury. The Journal of Gene Medicine 2008 10 1 94 100
43. 4-induced subacute liver injury in mice. Biomedicine & Pharmacotherapy 2009 63 8 592 598 10.1016/j.biopha.2008.08.023
44. Karavia E. A., Papachristou D. J., Kotsikogianni I., Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice. The Journal of Nutritional Biochemistry 2013 24, no. 3 567 577
45. Jaouad L., de Guise C., Berrougui H., Age-related decrease in high-density lipoproteins antioxidant activity is due to an alteration in the PON1's free sulfhydryl groups. Atherosclerosis 2006 185 1 191 200
46. Brattin W. J., Glende E. A. Jr., Recknagel R. O., Pathological mechanisms in carbon tetrachloride hepatotoxicity. Journal of Free Radicals in Biology & Medicine 1985 1 1 27 38
47. Lu H., Zhu J., Zang Y., Cloning, high level expression of human paraoxonase-3 in Sf9 cells and pharmacological characterization of its product. Biochemical Pharmacology 2005 70 7 1019 1025
48. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 10.1016/0003-2697(79)90738-3
49. Rossoni G., Berti F., Trento F., Defibrotide normalizes cardiovascular function hampered by established atherosclerosis in the rabbit. Thrombosis Research 2000 97 2 29 38
50. Rull A., Camps J., Alonso-Villaverde C., Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators of Inflammation 2010 2010 11 326580 10.1155/2010/326580
51. Ho L., Zhao W., Dams-O'Connor K., Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease. Journal of Alzheimer's Disease: JAD 2012 31 2 301 313
52. Esplin M. S., Peltier M. R., Hamblin S., Monocyte chemotactic protein-1 expression is increased in human gestational tissues during term and preterm labor. Placenta 2005 26 8-9 661 671
53. Kharfi A., Akoum A., Correlation between decreased type-II interleukin-1 receptor and increased monocyte chemotactic protein-1 expression in the endometrium of women with endometriosis. American Journal of Reproductive Immunology 2001 45 4 193 199 10.1111/j.8755-8920.2001.450401.x
54. Tan T., Ozbalci C., Brugger B., Mcp1 and Mcp2, two novel proteins involved in mitochondrial lipid homeostasis. Journal of Cell Science 2013 126 16 3563 3574
55. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 362 6423 801 809
56. Mackness B., Hine D., Liu Y., Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochemical and Biophysical Research Communications 2004 318 3 680 683
57. Aleshin S., Reiser G., Role of the peroxisome proliferator-activated receptors (PPAR)-alpha, beta/delta and gamma triad in regulation of reactive oxygen species signaling in brain. Biological Chemistry 2013 394 12 1553 1570
58. Andreeva-Gateva P., Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism. Annales de Biologie Clinique 2003 61 3 295 303
59. Belfiore A., Genua M., Malaguarnera R., PPAR- γ agonists and their effects on IGF-I receptor signaling: implications for cancer. PPAR Research 2009 2009 18 830501 10.1155/2009/830501
60. Camps J., Garcia-Heredia A., Rull A., PPARs in regulation of paraoxonases: control of oxidative stress and inflammation pathways. Control of Oxidative Stress and Inflammation Pathways 2012 2012 10 616371 10.1155/2012/616371
61. Peng W., Zhang C., Lv H., Comparative evaluation of the protective potentials of human paraoxonase 1 and 3 against CCl4-induced liver injury. Toxicology Letters 2010 193 2 159 166
62. Furnsinn C., Willson T. M., Brunmair B., Peroxisome proliferator-activated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport. Diabetologia 2007 50 1 8 17
63. Zheng Y., Patel A. B., Narayanaswami V., Retention of alpha-helical structure by HDL mimetic peptide ATI-5261 upon extensive dilution represents an important determinant for stimulating ABCA1 cholesterol efflux with high efficiency. Biochemical and Biophysical Research Communications 2013 441 1 71 76
64. Reboul E., Dyka F. M., Quazi F., Cholesterol transport via ABCA1: new insights from solid-phase binding assay. Biochimie 2013 95 4 957 961
65. Fan Y., Wang Y., Tang Z., Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 315 321